...
首页> 外文期刊>World Journal of Cardiovascular Surgery >Outcomes of Extracorporeal Membrane Oxygenation in Blood Culture Positive Septic Patients
【24h】

Outcomes of Extracorporeal Membrane Oxygenation in Blood Culture Positive Septic Patients

机译:血液培养阳性脓毒症患者体外膜氧的结果

获取原文
           

摘要

INTRODUCTION : Extracorporeal membrane oxygenation (ECMO) is commonly used for refractory cardiac or respiratory failure. There are reported cases of successful use of ECMO in patients with septic shock; however, there is a lack of evidence to prove its overall efficacy. Thus, we conducted this study to analyze the relationship between sepsis and ECMO in our own patients. METHODS : 305 patients who were placed on ECMO between 2010 and 2020 were identified within an IRB-approved database. Their clinical outcomes were an alyzed with a specific focus on patients who were septic before or during ECMO, defined as a positive blood culture. Group S was composed of patients with a positive blood culture before or during ECMO, while Group N was composed of all patients without a positive blood culture before or during ECMO. The primary outcome compared between groups was ECMO survival rate. RESULTS : Among the 305 patients on ECMO, 58 (19%) were in Group S and 247 (81%) were in Group N. ECMO survival rates were 45% in Group S and 62% in Group N (p = 0.017). CONCLUSION : Of our 305 patients, patients who were septic upon ECMO placement or those who developed sepsis during ECMO had worse ECMO survival rates than non-septic patients. Ultimately, patients who are septic or have a high probability of becoming septic may not be indicated for ECMO placement, and cautious administration of ECMO to these patients may be necessary.
机译:介绍:体外膜氧合(ECMO)通常用于难治性心脏或呼吸衰竭。报告患者在脓毒休克患者中成功使用ECMO的病例;然而,缺乏证据证明其整体疗效。因此,我们进行了这项研究,分析了我们自己患者的败血症和Ecmo之间的关系。 方法:在2010年至2020年间在IRB批准的数据库中确定了305名患者。他们的临床结果是一种含有特异性专注于脓毒症之前或在ECMO之前或期间的患者的患者,被定义为积极的血液培养。组S由Ecmo之前或期间患有血液培养的患者组成,而NE患者由ECMO之前或期间的所有患者组成。群体之间的主要结果是Ecmo存活率。 结果:在ECMO上305名患者中,58名(19%)在S组中,247(81%)在N群中,群体生存率为45%,群体中的62%(P = 0.017)。 结论:我们305名患者,ECMO放置后腐败的患者或在ECMO期间开发败血症的患者比非脓毒症患者更糟糕的ECMO生存率。最终,由于ECMO放置,可能没有表明脓毒症或具有脓毒症的高概率的患者,并且可能需要对这些患者的谨慎施用ECMO。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号